PlainVisa
2026 data Public-data reference Official source

BostonGene Corporation

A DOL Labor Condition Application record spanning FY2025–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
3
DOL-certified
100%
Median offered wage
$203,333

Waltham, MA NAICS: 513210

How many H-1B LCA filings list BostonGene Corporation?

U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming BostonGene Corporation from FY2025 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

BostonGene Corporation vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

3 52221st of 122824 higher than 70,603 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2025–FY2026

According to U.S. Department of Labor OFLC LCA disclosure files (FY2025–FY2026). Headquartered in Waltham, MA. Methodology.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

LCA filing shape · BostonGene Corporation

Derived from this employer's disclosed LCAs on file (FY2025–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $190,000$230,000 .

Title concentration

  • Director, BioPharma Business Development 2 · 66.7% · $190,000
  • Head of Quality Assurance and Regulatory Affairs 1 · 33.3% · $230,000

Worksite counties

  • WALTHAM CITY, MA 2 · 100%

Local thin filer

BostonGene Corporation (Waltham, MA) has 3 disclosed LCA s with worksites in a single state on this extract. Top title: Director, BioPharma Business Development. Small-N percentages swing hard on one withdrawn filing.

Recent LCA Filings

Latest H-1B labor condition applications filed by BostonGene Corporation

Job Title Location Salary Status Year
Director, BioPharma Business Development Waltham, MA $190,000 Certified - Withdrawn FY2026
Head of Quality Assurance and Regulatory Affairs Waltham, MA $230,000 Certified FY2025
Director, BioPharma Business Development Waltham, MA $190,000 Certified FY2025

Nationwide peers near BostonGene Corporation's 3-LCA band

Cross-state DOL neighbors for BostonGene Corporation - LCA filing-count and offered-wage axes, outside MA.

Common Questions

How many H-1B LCA filings list BostonGene Corporation?

BostonGene Corporation is listed in 3 DOL Labor Condition Application filings covering 3 listed worker positions from FY2025 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does BostonGene Corporation's LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, BostonGene Corporation ranks #40445 by total LCA filing count (3 filings). 70,603 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

How often are BostonGene Corporation's LCAs certified by the Labor Department?

BostonGene Corporation has a 100% DOL certification rate, with 3 out of 3 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What does BostonGene Corporation list as the offered wage on its LCAs?

The average offered wage listed in BostonGene Corporation's LCAs is $203,333. Listed wages range from $190,000 to $230,000 and are not verified actual compensation.

Which job titles appear most often in BostonGene Corporation's LCA filings?

The top job titles in BostonGene Corporation's LCA filing records include Director, BioPharma Business Development, Head of Quality Assurance and Regulatory Affairs. The most common listed title is Director, BioPharma Business Development with 2 LCA filings at an average listed offered wage of $190,000. This does not establish actual job openings, hiring, or approved petitions.

Where is BostonGene Corporation located?

BostonGene Corporation is headquartered in Waltham, MA.

Is BostonGene Corporation classified as H-1B dependent under DOL rules?

No, BostonGene Corporation is not classified as H-1B dependent.

What is the year-over-year trend in BostonGene Corporation's LCA filings?

BostonGene Corporation is listed in 2 LCA filings in FY2025 and 1 in FY2026. The average listed offered wage changed from $210,000 to $190,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with BostonGene Corporation

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-ELITE.

What to do with this profile

Use the DOL LCA record for BostonGene Corporation to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.